Press release
2025-2034 Mantle Cell Lymphoma Therapeutics Market Roadmap: Insights for Competitive Advantage
Mantle Cell Lymphoma Therapeutics
How Large Will the Mantle Cell Lymphoma Therapeutics Market Size By 2025?
The market size for mantle cell lymphoma therapeutics has seen a solid growth in the past few years. The market is projected to escalate from $2.42 billion in 2024 to $2.6 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.1%. Factors contributing to the growth during the historic period include advancements in research, successful clinical trials, bettered diagnostic instruments, expanded access to treatment, and cooperative research efforts.
How Big Is the Mantle Cell Lymphoma Therapeutics Market Size Expected to Grow by 2029?
The market space for therapeutics in mantle cell lymphoma is projected to witness substantial growth in the upcoming years, expanding to "$3.5 billion in 2029 with a compounded annual growth rate (CAGR) of 7.7%. Factors such as advancements in targeted therapies, novelty in immunotherapy, the rise of personalized medicine, market globalization, and escalating incidence rates contribute to the predicted growth in this period. Key trends expected to shape the forecast period include progress in immunotherapy, development in precision medicine and biomarkers, targeted therapies tailored for specific pathways, combined treatment methods, and the incorporation of artificial intelligence (AI).
View the full report here:
https://www.thebusinessresearchcompany.com/report/mantle-cell-lymphoma-therapeutics-global-market-report
Which Key Market Drivers Powering Mantle Cell Lymphoma Therapeutics Market Expansion and Growth?
The increased incidence of mantle cell lymphoma is anticipated to drive the expansion of the mantle cell lymphoma therapeutics market. Mantle cell lymphoma (MCL), a form of non-Hodgkin lymphoma (NHL) that affects the lymphatic system, can be managed and treated with the help of mantle cell lymphoma therapeutics, which lead to enhanced patient prognosis, extended survival, and alleviated disease impact. For example, as reported by the National Library of Medicine, a biomedical library administered by the United States Federal Government, in December 2022, the yearly incident rate of mantle cell lymphoma is one in every 200,000 individuals. This represents 5% of all instances of non-Hodgkins lymphomas. Hence, the increasing incidence of mantle cell lymphoma is propelling the mantle cell lymphoma therapeutics market's growth.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10813&type=smp
Which Emerging Trends Are Transforming the Mantle Cell Lymphoma Therapeutics Market in 2025?
A significant trend emerging in the mantle cell lymphoma therapeutics market is the growth of targeted therapy medications. Leading corporations within this market are focusing on the creation of such medications to maintain their standing. A prime example is AstraZeneca plc., a pharmaceutical firm based in the UK. In March 2023, the company acquired approval for Calquence (acalabrutinib) from the National Medical Products Administration (NMPA) to distribute the drug in China, targetted at adult patients diagnosed with mantle cell lymphoma (MCL). Calquence (acalabrutinib) is a specific Bruton's tyrosine kinase (BTK) inhibitor that provides a manageable and effective new treatment alternative for managing mantle cell lymphoma.
What Are the Emerging Segments in the Mantle Cell Lymphoma Therapeutics Market?
The mantle cell lymphoma therapeutics market covered in this report is segmented -
1) By Type: Combination Therapy, Monotherapy
2) By Mechanism of Action: Bruton Tyrosine Kinase Inhibitors, Alkylating Agents, Deoxyribonucleic Acid Synthesis Inhibitors, Microtubule Inhibitors, Monoclonal Antibodies, Other Mechanisms
3) By Route of Administration: Oral, Parenteral
4) By Application: Hospital, Research Institute, Other Applications
Subsegments:
1) By Combination Therapy: Chemotherapy Combinations, Targeted Therapy Combinations, Immunotherapy Combinations
2) By Monotherapy: Single-Agent Chemotherapy, Targeted Therapy Monotherapy, Immunotherapy Monotherapy
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10813&type=smp
Who Are the Global Leaders in the Mantle Cell Lymphoma Therapeutics Market?
Major companies operating in the mantle cell lymphoma therapeutics market include AstraZeneca plc, Celgene Corporation, Johnson & Johnson Consumer Inc., Takeda Pharmaceutical Company Limited, Bayer Aktiengesellschaft, Eli Lilly and Company, Amgen Inc., GlaxoSmithKline plc, Kite Pharma Inc., Gilead Sciences Inc., AbbVie Inc., Bristol-Myers Squibb Company, Novartis AG, Merck & Co. Inc., Massive Bio Inc., Juno Therapeutics Inc., Nurix Therapeutics Inc., Janssen Biotech Inc., TG Therapeutics Inc., F. Hoffmann-La Roche AG, Astex Pharmaceuticals Inc., Astellas Pharma Inc., BeiGene Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Exelixis Inc., Hutchison China MediTech Limited, Incyte Corporation, Ionis Pharmaceuticals Inc.
Which are the Top Profitable Regional Markets for the Mantle Cell Lymphoma Therapeutics Industry?
North America was the largest region in the global mantle cell lymphoma therapeutics market in 2024. The regions covered in the mantle cell lymphoma therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10813
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2025-2034 Mantle Cell Lymphoma Therapeutics Market Roadmap: Insights for Competitive Advantage here
News-ID: 4182337 • Views: …
More Releases from The Business Research Company
Transformative Trends Impacting the Advanced Therapeutics Pharmaceutical Outsour …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Advanced Therapeutics Pharmaceutical Outsourcing Market Size By 2025?
The size of the advanced therapeutics pharmaceutical outsourcing market has experienced consistent growth in previous years. It is anticipated to increase from $8.07 billion in 2024 to $8.41 billion in 2025, reflecting a compound annual growth rate…
Navigating the Future: Sedative-Hypnotic Drugs Market Trends and Forecast Insigh …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sedative-Hypnotic Drugs Market Size Growth Forecast: What to Expect by 2025?
The market size for sedative-hypnotic drugs has witnessed robust growth in the past few years. It's projected to increase from $3.57 billion in 2024 to $3.86 billion in 2025, representing a compound annual growth rate (CAGR) of 8.0%.…
Increasing Awareness Of Age-Related Skin Issues Fuels Growth In The Serum Market …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Serum Market Size Growth Forecast: What to Expect by 2025?
The value of the serum market has experienced substantial growth recently, with an increase from $1.42 billion in 2024 projected to reach $1.56 billion in 2025. This represents a compound annual growth rate (CAGR) of 9.7%. The historical growth…
Role Of Rising Chronic Disease Incidence In Driving Growth Of The Narcotic Drug …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Narcotic Drugs Market Size By 2025?
In recent times, there has been stable growth in the market size of narcotic drugs. An elevation from $14.26 billion in 2024 to $14.71 billion in 2025, amounting to a compound annual growth rate (CAGR) of 3.1%, is predicted.…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
